B6.CB-Slc38a8em1Lmon/Cnbc

Status

Available to order

EMMA IDEM:15349
Citation informationRRID:IMSR_EM:15349 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.CB-Slc38a8em1Lmon/Cnbc
Alternative nameB6.CB-Slc38a8emA8578/Lmon
Strain typeEndonuclease-mediated
Allele/Transgene symbolSlc38a8em1Lmon
Gene/Transgene symbolSlc38a8

Information from provider

ProviderLluis Montoliu
Provider affiliationMolecular and Cellular Biology, CNB-CSIC
Genetic informationMouse mutation in the Slc38a8 gene generated using CRISPR/Cas9 genome editing tools resulting in the p.196Pro* mutation in the corresponding encoded protein (equivalent to p.Pro199* mutation in the SLC38A8 human gene), thereby truncating the carboxy-end of the protein. This mutation in the Slc28a8 mouse gene is most similar to the p.Gln200* mutation in the SLC38A8 human protein, resulting in the FHONDA (foveal hypoplasia, optic nerve decussation defects, and anterior segment dysgenesis) syndrome, a new recessive rare inherited disorder associated with visual impairments similar to those found in albinism. Hence, this mouse mutant is a suitable animal model to investigate the FHONDA syndrome.
Phenotypic informationHomozygous:
Externally, homozygous mutant mice are pigmented black (nonagouti), indistinguishable of C57BL/6J wild-type, with pigmentation levels in skin and eyes comparable to wild-type animals. Internally, at the level of the visual system, these mice show some empty areas in the retinal pigment epithelium (RPE) cells under light microscopy. Under electron microscopy, these RPE areas appeared as intracellular vacuoles. They also show a significant reduction of ipsilateral retinal ganglion cell fibers departing from the optic chiasm, as measured by unilateral anterograde labeling with DiI in +18.5 dpc embryos and anterograde tracing experiment in adult animals (2-3 months old) using the neuronal tracer CTB associated with AlexaFluor 555 or AlexaFluor 647 fluorochromes into each eye, respectively, to visualize the entire 3D retinal projections for both eyes. ERG analyses under scotopic conditions, to evaluate retinal function, show significantly smaller responses elicited by the higher intensity flashes in homozygous mutant mice. Their visual acuity, assessed with the optomotor test, exhibited a statistically significant reduction in homozygous mutant mice, compared to wild-type animals.

Heterozygous:
Externally, heterozygous mutant mice are pigmented black (nonagouti), indistinguishable of C57BL/6J wild-type, with pigmentation levels in skin and eyes comparable to wild-type animals. Internally, at the level of the visual system, these mice show some empty areas in the RPE cells under light microscopy (fewer than with homozygous mutant mice). Under electron microscopy, these RPE areas appeared as intracellular vacuoles. Heterozygous animals do not show a reduction of ipsilateral retinal ganglion cell fibers departing from the optic chiasm. ERG analyses under scotopic conditions, showed significant differences with homozygous mutant mice. Their visual acuity, assessed with the optomotor test, exhibited a statistically significant reduction in heterozygous mutant mice, compared to wild-type animals.
Breeding historyThe mouse mutation was originally obtained in a hybrid background B6CBAF2. Thereafter, the selected founder (A8578) was subsequently backcrossed five times to C57BL/6J directly purchased to Charles River. Therefore, the current genetic background of the mouse line is >98.4% C57BL/6J.
References
  • A Slc38a8 Mouse Model of FHONDA Syndrome Faithfully Recapitulates the Visual Deficits of Albinism Without Pigmentation Defects.;Guardia Ana, Fernández Almudena, Seruggia Davide, Chotard Virginie, Sánchez-Castillo Carla, Kutsyr Oksana, Sánchez-Sáez Xavier, Zurita Esther, Cantero Marta, Rebsam Alexandra, Cuenca Nicolás, Montoliu Lluís, ;2023;Investigative ophthalmology & visual science;64;32; 37862028
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain
Animals used for archivingheterozygous C57BL/6J males

Disease and phenotype information

IMPC phenotypes (gene matching)

Literature references

  • A Slc38a8 Mouse Model of FHONDA Syndrome Faithfully Recapitulates the Visual Deficits of Albinism Without Pigmentation Defects.;Guardia Ana, Fernández Almudena, Seruggia Davide, Chotard Virginie, Sánchez-Castillo Carla, Kutsyr Oksana, Sánchez-Sáez Xavier, Zurita Esther, Cantero Marta, Rebsam Alexandra, Cuenca Nicolás, Montoliu Lluís, ;2023;Investigative ophthalmology & visual science;64;32; 37862028

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).